Post job

Zynerba Pharma overview

Industry
Pharmaceutical
Revenue
Headquarters
Employees
26
Founded in
Website
Organization type
Public
Social media
Zynerba Pharmaceuticals is dedicated to the development of innovative transdermal cannabinoid treatments for patients with high unmet medical needs using modern drug delivery technology and appropriate regulatory pathways. Zynerba is developing two therapeutic candidates based on proprietary transdermal technologies that, if successfully developed, may allow sustained, consistent and controlled delivery of therapeutic levels of cannabinoids. Transdermal delivery reduces adverse effects associated with oral dosing. ZYN001 will be studied in fibromyalgia, neuropathic pain and chronic cancer pain utilizing a synthetically manufactured prodrug of THC in a transdermal patch to deliver THC through the skin and into the bloodstream. Zynerba expects to initiate ZYN001 Phase 1 clinical studies in 2Q 2015. ZYN002 will be studied in epilepsy and rheumatoid arthritis, utilizing a proprietary gel to deliver synthetically manufactured cannabidiol (CBD), a non-psychotropic cannabinoid, through the skin and into the bloodstream. Zynerba expects to initiate ZYN002 Phase 1 clinical studies in 3Q 2015. Learn more at www.zynerba.com and follow the company on Twitter at @ZynerbaPharma.
Based in Pennsylvania, Zynerba Pharma is a small pharmaceutical company with only 26 employees and an annual revenue of $86,000.

Zynerba Pharma's mission statement

To improve the lives of patients battling severe health conditions including refractory epilepsy, osteoarthritis, Fragile X syndrome, fibromyalgia and peripheral neuropathic pain through synthetic cannabinoid therapeutics formulated for transdermal delivery.

In demand companies are hiring! Let Zippi apply for you!

Floating question marks illustration
-

Zynerba Pharma employee reviews

Be the first to review!

Do you work at Zynerba Pharma?

Help job seekers learn about working at Zynerba Pharma

On this page

Be the first to review Zynerba Pharma

Anonymously rate your employee experience

Your opinion can help other job seekers

Do you like working at Zynerba Pharma?

The team at Zynerba Pharma

  • The founders of Zynerba Pharma is Audra Stinchcomb.
  • The key people at Zynerba Pharma are Armando Anido and Audra Stinchcomb.
Key people
Armando Anido
Audra Stinchcomb

Zynerba Pharma rankings

Zynerba Pharma is ranked #83 on the Best Pharmaceutical companies to work for in Pennsylvania list. Zippia's Best Places to Work lists provide unbiased, data-based evaluations of companies. Rankings are based on government and proprietary data on salaries, company financial health, and employee diversity.

Read more about how we rank companies.

Rate Zynerba Pharma's commitment to diversity and inclusion.

Zippia waving zebra

Do you work at Zynerba Pharma?

Were you satisfied with Zynerba Pharma's salary and benefits?

Zynerba Pharma financial performance

3.6
Performance score

We calculated the performance score of companies by measuring multiple factors, including revenue, longevity, and stock market performance.

Zynerba Pharma currently has 86.0K in revenue. Zynerba Pharma's most recent quarter produced 7.3k (q1'2016).

Zynerba Pharma annual revenue

$815,000
$652,000
$489,000
$326,000
$163,000
$0
2014
2015
2016
2018

Are you an executive, HR leader, or brand manager at Zynerba Pharma?

Claiming and updating your company profile on Zippia is free and easy.

Zynerba Pharma FAQs

Search for jobs

Zippia gives an in-depth look into the details of Zynerba Pharma, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Zynerba Pharma. The employee data is based on information from people who have self-reported their past or current employments at Zynerba Pharma. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Zynerba Pharma. The data presented on this page does not represent the view of Zynerba Pharma and its employees or that of Zippia.

Zynerba Pharma may also be known as or be related to ZYNERBA PHARMACEUTICALS INC., Zynerba Pharma, Zynerba Pharmaceuticals, Zynerba Pharmaceuticals Inc and Zynerba Pharmaceuticals, Inc.